将阿片类药物流行病理解为环境不公正
本文探讨阿片类药物使用相关死亡的种族差异与环境正义之间的概念联系,提出种族差异通过分配正义、能力正义、承认正义和程序正义四种途径表现为环境不公正,并构建社会生态模型以刻画和应对种族少数群体空间中阿片类药物分销、使用和管理造成的不公正。
要点
- 阿片类药物使用相关死亡的种族差异可通过环境正义框架理解。
- 种族少数群体社区面临阿片类药物可及性和刑事化程度更高。
- 精神卫生治疗、丁丙诺啡提供者和减害资源可及性或利用有限。
核心结论
- 阿片类药物使用相关死亡的种族差异通过分配正义、能力正义、承认正义和程序正义四种途径表现为环境不公正。
研究设计与样本
- 本文为概念性文章,探讨阿片类药物使用相关死亡的种族差异与环境正义之间的联系。
主要发现
- 分配正义方面:种族少数群体社区中阿片类药物可及性和刑事化程度升高。
- 能力正义方面:上述社区中精神卫生治疗、丁丙诺啡提供者和减害资源的可及性或利用有限。
- 承认正义方面:治疗和减害场所在上述社区中不成比例地安置。
- 程序正义方面:土著植物及中国/亚洲鸦片遭受生物殖民剥削和商品化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The conceptual link between racial disparities in opioid use-related deaths and environmental justice, a valuable socioecologic paradigm for contextualizing how racial vulnerabilities are ecologically forged, has not been duly explored. Exploring and filling this gap, this article highlights four primary ways through which racial disparities in opioid use manifest as a matter of environmental (in)justice, namely in terms of (1) distributive justice (elevated availability and criminalization of opioids in racially minoritized communities), (2) capability justice (limited access to or uptake of mental health treatment, buprenorphine providers, and harm reduction resources in said communities), (3) recognitional justice (disproportionate placement of eyesore treatment and harm reduction sites in said communities), and (4) procedural justice (biocolonial exploitation and commodification of Indigenous plants and Chinese/Asian opium). In delineating the various modes of community and individual-level deprivation that are implicated, this article arrives at a socioecologic model focused on characterizing and addressing the environmental injustice perpetrated through opioid distribution, use, and management in racially minoritized spaces.
引用
- Ezell JM. Understanding the Opioid Epidemic as an Environmental Injustice. Am J Prev Med. 2025. PMID: 40812487. doi:10.1016/j.amepre.2025.108047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。